Saphenous Vein Cannulation in Infants and Small Children

December 25, 2017 updated by: Satoshi Hanada

Ultrasound-image Guided Versus Traditional Landmark Technique for Saphenous Vein Cannulation in Infants and Small Children

The purpose of this study is to compare the two different saphenous vein cannulation techniques; real-time ultrasound image-guided technique (Ultrasound group) vs. traditional landmark technique (Landmark group).

Study Overview

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa Hospitals & Clinics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 4 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Pediatric patient undergoing scheduled surgery which requires venous cannulation.
  2. Term neonates and children < 4 years old weighing >/= 3 kg

Exclusion Criteria:

  1. Patient with visible saphenous vein
  2. Patient with no detectable saphenous vein under ultrasound
  3. Patient with a skin wound or infection around puncture site
  4. Patient with recent venous puncture at the puncture site (less than 1 month)
  5. Patient with thrombus in saphenous vein or hematoma formation around the vein detected by ultrasound.
  6. Patient with any emergency surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Landmark group
An operator is not allowed to use an ultrasound. A 22 or 24 G catheter will be advanced blindly toward the expected location of the saphenous vein at the level of the medial malleolus. Once blood appears in the hub, then the catheter will be advanced into the saphenous vein.
Intravenous cannulation to saphenous vein
Active Comparator: Ultrasound group
An operator will identify the saphenous vein by using ultrasound with a linear transducer (L15-7io) in short axis view. A 22 or 24 G catheter will be advanced until the tip of the needle is seen on the ultrasound image. The needle is then advanced until blood appears in the hub. The catheter is then advanced into the saphenous vein.
Intravenous cannulation to saphenous vein
Portable, bed-side ultrasound to detect saphenous vein

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of Participants With First Attempt Success of Saphenous Vein Cannulation
Time Frame: 10 minutes
10 minutes

Secondary Outcome Measures

Outcome Measure
Time Frame
Percentage of Participants With Success of Saphenous Vein Cannulation Within 3 Attempts of Needle Insertion, or a 10 Minute Time Period.
Time Frame: 10 minutes
10 minutes
Time Required for Overall Successful Venous Cannulation.
Time Frame: 10 minutes
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Satoshi Hanada, MD, University of Iowa Hospitals & Clinics

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

July 1, 2014

Study Completion (Actual)

July 1, 2014

Study Registration Dates

First Submitted

August 14, 2013

First Submitted That Met QC Criteria

August 14, 2013

First Posted (Estimate)

August 19, 2013

Study Record Updates

Last Update Posted (Actual)

January 23, 2018

Last Update Submitted That Met QC Criteria

December 25, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • V-line study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Saphenous Vein Cannulation

Clinical Trials on Saphenous vein cannulation

3
Subscribe